Dynamic Technology Lab Private Ltd Takes $295,000 Position in Addus HomeCare Co. (NASDAQ:ADUS)

Dynamic Technology Lab Private Ltd purchased a new position in Addus HomeCare Co. (NASDAQ:ADUS) in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 2,220 shares of the company’s stock, valued at approximately $295,000.

Several other institutional investors and hedge funds also recently bought and sold shares of ADUS. GAMMA Investing LLC lifted its holdings in shares of Addus HomeCare by 33.8% in the 2nd quarter. GAMMA Investing LLC now owns 744 shares of the company’s stock worth $86,000 after acquiring an additional 188 shares during the last quarter. First Hawaiian Bank purchased a new stake in shares of Addus HomeCare in the second quarter worth approximately $418,000. Harbor Capital Advisors Inc. lifted its stake in shares of Addus HomeCare by 239.2% during the 2nd quarter. Harbor Capital Advisors Inc. now owns 28,240 shares of the company’s stock worth $3,279,000 after acquiring an additional 19,914 shares during the last quarter. Guinness Asset Management LTD boosted its holdings in Addus HomeCare by 3.3% during the 2nd quarter. Guinness Asset Management LTD now owns 5,001 shares of the company’s stock valued at $580,000 after acquiring an additional 158 shares during the period. Finally, SG Americas Securities LLC bought a new position in Addus HomeCare in the 2nd quarter valued at $842,000. 95.35% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

ADUS has been the subject of a number of recent analyst reports. TD Cowen boosted their target price on shares of Addus HomeCare from $128.00 to $137.00 and gave the company a “buy” rating in a research note on Thursday, August 8th. Stephens upped their target price on shares of Addus HomeCare from $143.00 to $145.00 and gave the stock an “overweight” rating in a research note on Wednesday, November 6th. KeyCorp started coverage on shares of Addus HomeCare in a research note on Friday, October 11th. They set an “overweight” rating and a $150.00 price target for the company. Oppenheimer boosted their price target on Addus HomeCare from $140.00 to $145.00 and gave the company an “outperform” rating in a report on Monday, September 23rd. Finally, Macquarie restated an “outperform” rating and set a $139.00 price objective on shares of Addus HomeCare in a report on Monday, November 4th. One research analyst has rated the stock with a sell rating, eight have issued a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $131.63.

Insider Buying and Selling at Addus HomeCare

In related news, Director Esteban Lopez sold 500 shares of Addus HomeCare stock in a transaction dated Wednesday, September 4th. The stock was sold at an average price of $130.03, for a total transaction of $65,015.00. Following the completion of the sale, the director now owns 3,866 shares of the company’s stock, valued at $502,695.98. The trade was a 11.45 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO R Dirk Allison sold 12,500 shares of the company’s stock in a transaction that occurred on Monday, November 25th. The shares were sold at an average price of $123.16, for a total value of $1,539,500.00. Following the completion of the sale, the chief executive officer now owns 141,897 shares in the company, valued at approximately $17,476,034.52. This represents a 8.10 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 13,500 shares of company stock worth $1,668,265. 4.60% of the stock is owned by corporate insiders.

Addus HomeCare Price Performance

Addus HomeCare stock opened at $122.84 on Monday. Addus HomeCare Co. has a 1-year low of $85.43 and a 1-year high of $136.12. The business has a fifty day moving average price of $127.30 and a 200-day moving average price of $123.66. The stock has a market capitalization of $2.23 billion, a price-to-earnings ratio of 28.11, a PEG ratio of 2.15 and a beta of 1.04.

Addus HomeCare (NASDAQ:ADUS) last issued its quarterly earnings results on Monday, November 4th. The company reported $1.30 earnings per share for the quarter, topping analysts’ consensus estimates of $1.28 by $0.02. The business had revenue of $289.80 million for the quarter, compared to analyst estimates of $289.42 million. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. The company’s revenue was up 7.1% on a year-over-year basis. During the same quarter in the previous year, the firm earned $1.03 earnings per share. On average, equities research analysts anticipate that Addus HomeCare Co. will post 4.58 earnings per share for the current fiscal year.

Addus HomeCare Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.